SESSION TITLE: Safety and Effectiveness of COPD Treatments
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Tuesday, October 25, 2016 at 11:00 AM - 12:15 PM
PURPOSE: Chronic obstructive pulmonary disease (COPD) has a significant socioeconomic burden. After hospitalization for an exacerbation of COPD, readmission rates are >20%. Patients with COPD are commonly discharged on dry power inhalers (DPI) after being admitted for COPD exacerbation. DPIs require an initial fast inhalation to break up pellets into particles that can be deposited deep into the respiratory tract. However, 20% of patients with advanced COPD did not reach the recommended peak inspiratory flow rate (PIF) for DPI devices. Patients with suboptimal PIF have fewer days to all cause and COPD readmissions. Our aim is to determine the benefit of nebulized therapies instead of DPI for patients with suboptimal PIF.